Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
8,808,211
-
Share change
-
+662,921
-
Total reported value
-
$32,594,250
-
Price per share
-
$3.70
-
Number of holders
-
61
-
Value change
-
+$2,447,199
-
Number of buys
-
31
-
Number of sells
-
19
Institutional Holders of APPLIED GENETIC TECHNOL CORP - COM (AGTC) as of Q2 2018
As of 30 Jun 2018,
APPLIED GENETIC TECHNOL CORP - COM (AGTC) was held by
61 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
8,808,211 shares.
The largest 10 holders included
INTERWEST VENTURE MANAGEMENT CO, DIMENSIONAL FUND ADVISORS LP, ACADIAN ASSET MANAGEMENT LLC, RENAISSANCE TECHNOLOGIES LLC, VANGUARD GROUP INC, PRICE T ROWE ASSOCIATES INC /MD/, DAFNA Capital Management LLC, Man Group plc, AJO, LP, and BlackRock Inc..
This page lists
61
institutional shareholders reporting positions in this security
for the Q2 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.